ERBB3 and cancer: Nevertheless, p-ErbB3 levels declined instantly in response to ErbB2 blockade by both agents (Fig. 1d; Supplementary Fig. 1A,B), and in most ErbB2-depended cancer cells there was a permanent reduction of p-ErbB3.